Hansa Biopharma to host Capital Markets Day on Thursday October 29, 2020 in Copenhagen
Focusing on transformation into a commercial stage biopharmaceutical company and the potential of its unique antibody-cleaving enzyme platform beyond transplantation in areas such as autoimmunity and gene therapyLund, Sweden September 17, 2020. Hansa Biopharma (“Hansa”), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company will host its 2020 Capital Markets Day (CMD) in Copenhagen on Thursday October 29, from 13:30-17:30 CET (7:30am-11:30am EST). The CMD event will be focused around Hansa Biopharma’s transformation into a fully